mercredi 8 février 2017

Onco Actu du 8 février 2017

3.1.1 Tabac - e-cigs

Long-term vaping 'far safer than smoking' says 'landmark' study [NHS Choices]

E-cigarettes act as gateway to smoking for teens, scientists warn [The Telegraph]

Plain Old Vaping Gives Way to ‘Dripping’ Among Teenagers, Study Says [NY Times]

3.3 Prévention - Vaccins

Merck's Gardasil faces 'negative impact' of HPV schedule change: exec [FiercePharma]

American Cancer Society: 2 HPV Shots Instead of 3 OK for Ages 9-14 [ACS]

Too few U.S. teens getting flu and cancer vaccines [Reuters]

4.2 Dép., diag. & prono. - Génome

Physicians fail to recommend genetic testing to many high-risk breast cancer patients [Stanford Medicine]

Women With Breast Cancer Miss Out On Recommended Genetic Testing [NPR]

Twenty Years Later, And We Still Don’t Routinely Offer BRCA Test To Women At High Risk For Breast Cancer [Dr Len's Blog]

5.12 Immunothérapies

Scientists discover why some cancers may not respond to immunotherapy [UCLA]

5.12.1 Immunothérapies - partenariats

Cancer Research Technology, UCL, and Tusk Therapeutics join forces to develop cancer immunotherapies [Cancer Research UK]

5.12.2 Immunothérapies - CAR-T

Cellectis Gains FDA Nod to Test New Gene-Edited Cancer Treatment [The Street]

5.12.5 Immunothérapies - Pharma

MSD aims to get the jump on BMS treating bladder cancer [Pharmafile]

Europe Cancer Immunotherapy Market Report 2017 [ReportsnReports]

5.2 Pharma

Nanobiotix appoints Oncology industry veteran as Chief Operating Officer [European Pharmaceutical Review]

GW Pharma’s cannabis-derived combo med helps brain cancer patients [FierceBiotech]

FDA lifts clinical hold on Northwest Bio cancer vax trial [FierceBiotech]

GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma [GW Pharmaceuticals]

6.10.1 Politiques (USA)

Biotech leaders take on Trump’s immigration ban, warn of mounting harm [FierceBiotech]

Biotechnology Executives Oppose Trump Immigration Policy [Forbes]

6.8 Communication

It’s time for journalists to stop using the word ‘controversial’ to describe medical science [HealthNewsReview]

6.9 Controverses

Dispute over the legal rights to an anticancer agent continues [C&EN]